Amygdala Neurons Reduced in Adulthood With Autism

Share this content:
Amygdala Neurons Reduced in Adulthood With Autism
Amygdala Neurons Reduced in Adulthood With Autism

TUESDAY, March 27, 2018 (HealthDay News) -- In neurotypical development, there is an increase in the number of mature neurons in the basal and accessory basal nuclei, whereas an initial excess of amygdala neurons is seen during childhood in autism spectrum disorder (ASD), followed by a reduction in adulthood, according to a study published online March 20 in the Proceedings of the National Academy of Sciences.

Thomas A. Avino, Ph.D., from the University of California, Davis, in Sacramento, and colleagues reported the results of a stereological analysis of the number of neurons in amygdala nuclei of 52 human brains aged 2 to 48 years. Twenty-four brains were neurotypical, and 28 were ASD.

The researchers found that the number of mature neurons in the basal and accessory basal nuclei increased from childhood to adulthood in neurotypical development, which coincided with a decrease of immature neurons within the paralaminar nucleus. In contrast, there was initial excess of amygdala neurons during childhood in individuals with ASD; across nuclei there was a reduction in neurons in adulthood.

"We propose that there is a long-term contribution of mature neurons from the paralaminar nucleus to other nuclei of the neurotypical human amygdala and that this growth trajectory may be altered in ASD, potentially underlying the volumetric changes detected in ASD and other neurodevelopmental or neuropsychiatric disorders," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »